Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M22,498Revenue (TTM) $M9,938Net Margin (%)8.1Altman Z-Score1.8
Enterprise Value $M29,621EPS (TTM) $1.6Operating Margin %15.5Piotroski F-Score5
P/E(ttm)26.8Beneish M-Score-2.7Pre-tax Margin (%)9.0Higher ROA y-yN
Price/Book2.110-y EBITDA Growth Rate %13.1Quick Ratio2.7Cash flow > EarningsY
Price/Sales2.25-y EBITDA Growth Rate %7.5Current Ratio3.2Lower Leverage y-yN
Price/Free Cash Flow18.1y-y EBITDA Growth Rate %2.9ROA % (ttm)3.4Higher Current Ratio y-yY
Dividend Yield %--PEG3.6ROE % (ttm)8.1Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M535ROIC % (ttm)8.2Gross Margin Increase y-yN

Gurus Latest Trades with MYL

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
MYLDavid Einhorn 2016-06-30 Add1.63%$38.62 - $48.8
($44.27)
$ 42.06-5%Add 71.11%4,945,000
MYLJohn Paulson 2016-06-30 Reduce-0.46%$38.62 - $48.8
($44.27)
$ 42.06-5%Reduce -5.60%22,028,061
MYLJoel Greenblatt 2016-06-30 Sold Out -0.44%$38.62 - $48.8
($44.27)
$ 42.06-5%Sold Out0
MYLVanguard Health Care Fund 2016-06-30 Add0.12%$38.62 - $48.8
($44.27)
$ 42.06-5%Add 4.82%27,965,385
MYLMario Gabelli 2016-06-30 Reduce$38.62 - $48.8
($44.27)
$ 42.06-5%Reduce -17.65%14,000
MYLDavid Tepper 2016-03-31 Sold Out -0.92%$41.42 - $54.09
($48.28)
$ 42.06-13%Sold Out0
MYLJoel Greenblatt 2016-03-31 Add0.44%$41.42 - $54.09
($48.28)
$ 42.06-13%Add 9178.19%837,728
MYLVanguard Health Care Fund 2016-03-31 Add0.25%$41.42 - $54.09
($48.28)
$ 42.06-13%Add 10.00%26,679,385
MYLJohn Paulson 2016-03-31 Add0.19%$41.42 - $54.09
($48.28)
$ 42.06-13%Add 2.38%23,335,861
MYLKeeley Asset Management Corp 2016-03-31 Sold Out -0.09%$41.42 - $54.09
($48.28)
$ 42.06-13%Sold Out0
MYLMario Gabelli 2016-03-31 Reduce$41.42 - $54.09
($48.28)
$ 42.06-13%Reduce -35.73%17,000
MYLDavid Einhorn 2015-12-31 Buy 2.86%$39.16 - $55.28
($48.35)
$ 42.06-13%New holding2,890,000
MYLDavid Tepper 2015-12-31 Add0.41%$39.16 - $55.28
($48.35)
$ 42.06-13%Add 81.62%853,749
MYLJohn Paulson 2015-12-31 Add0.29%$39.16 - $55.28
($48.35)
$ 42.06-13%Add 4.02%22,794,061
MYLVanguard Health Care Fund 2015-12-31 Add0.11%$39.16 - $55.28
($48.35)
$ 42.06-13%Add 4.26%24,253,075
MYLJoel Greenblatt 2015-12-31 Buy 0.01%$39.16 - $55.28
($48.35)
$ 42.06-13%New holding9,029
MYLMario Gabelli 2015-12-31 Reduce-0.01%$39.16 - $55.28
($48.35)
$ 42.06-13%Reduce -60.67%26,450
MYLKeeley Asset Management Corp 2015-12-31 Reduce$39.16 - $55.28
($48.35)
$ 42.06-13%Reduce -8.09%51,580
MYLDavid Tepper 2015-09-30 Reduce-0.87%$39.8 - $71.49
($55.75)
$ 42.06-25%Reduce -52.50%470,071
MYLVanguard Health Care Fund 2015-09-30 Add0.64%$39.8 - $71.49
($55.75)
$ 42.06-25%Add 46.38%23,262,875
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

MYL is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


MYL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BRESCH HEATHER MCEO 2016-08-09Sell100,200$50-15.88view
MAROON JOSEPH C MDDirector 2016-06-03Buy1,670$44.95-6.43view
MAROON JOSEPH C MDDirector 2016-05-25Buy2,370$42.47-0.97view
Cindrich Robert JDirector 2016-05-25Buy1,190$42.47-0.97view
HIGGINS MELINA EDirector 2016-05-12Buy19,900$38.688.74view
HIGGINS MELINA EDirector 2016-05-06Buy100$38.698.71view
HIGGINS MELINA EDirector 2016-04-28Buy35,000$42.92-2view
COURY ROBERT JExecutive Chairman 2016-04-05Sell217,755$45.96-8.49view
MAROON JOSEPH C MDDirector 2016-03-31Buy4,337$46.36-9.28view
PARRISH MARK WDirector 2016-03-17Buy1,705$44-4.41view

Press Releases about MYL :

Quarterly/Annual Reports about MYL:

News about MYL:

Articles On GuruFocus.com
Lee Ainslie’s Top 3 New Holdings Aug 29 2016 
Swiss Generics Manufacturer Has Strong 1st Half of Year Aug 22 2016 
10 Biotech and Specialty Pharma Bargains: Do You Have the Guts to Speculate? Jul 01 2016 
Growing Generic Drug Market a Good Opportuity for 2 India Firms May 30 2016 
Samuel Isaly Trades in Health Care Stocks in 1st Quarter Apr 27 2016 
John Keeley Comments on Mylan Labs Apr 26 2016 
Ackman to Testify About Valeant Before Senate Apr 26 2016 
Mawer's Investment Newsletter 1st Quarter Apr 15 2016 
Insiders Keep on Selling Facebook and Ford Apr 08 2016 
Buy Perrigo After a Big Selloff? Yes Apr 04 2016 

More From Other Websites
Generics or Specialty: Which Mylan Segment Is Growing Fastest? Sep 23 2016
You’ve Heard about the EpiPen Debacle, but Have You Heard This? Sep 23 2016
Are Mylan’s EpiPen Challenges Souring Analysts’ Views on Stock? Sep 23 2016
Next Drug Price Scandal Could Be Cost of Naloxone Sep 23 2016
The next EpiPen? Sep 23 2016
The Zacks Friday Finish Line Highlights: IPOs, Netflix, Comcast, Wells Fargo, Mylan Sep 23 2016
Endo Int'l: New CEO "Has His Work Cut Out For Him" Sep 23 2016
5 Most Shocking Congressional Testimonies by CEOs Sep 23 2016
Wells Fargo and Mylan: Corporate Devils or Unworthy Scapegoats? Sep 23 2016
CEO Isn't All That's Under Pressure at Mylan Sep 23 2016
USA Today On EpiPen Saga: Calling It 'Controversial' Is Far From Haphazard Sep 23 2016
[$$] US politicians lament inaction over price-gouging drug companies Sep 23 2016
Even Elizabeth Warren’s fury can’t shame America’s CEOs Sep 23 2016
5 things we still don’t know about EpiPen pricing after Mylan’s congressional beating Sep 23 2016
Parent bloggers question role in Mylan's EpiPen schools push Sep 23 2016
[$$] Overheard: Firms on Hot Seat, but Shares are Steady Sep 22 2016
[$$] Overheard Sep 22 2016
Mylan CEO: Reformulating EpiPen to Have Longer Shelf Life Sep 22 2016
Mylan CEO: Reformulating EpiPen to Have Longer Shelf Life Sep 22 2016
Gilead diving into M&A? Sep 22 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)